De Cristofaro Raimondo, Carotti Andrea, Akhavan Sepideh, Palla Roberta, Peyvandi Flora, Altomare Cosimo, Mannucci Pier Mannuccio
Haemostasis Research Centre, Institute of Internal Medicine and Geriatrics, Catholic University School of Medicine, Rome, Italy.
FEBS J. 2006 Jan;273(1):159-69. doi: 10.1111/j.1742-4658.2005.05052.x.
The catalytic competence of the natural thrombin mutant with deletion of the Lys9 residue in the A-chain (deltaK9) was found to be severely impaired, most likely due to modification of the 60-loop conformation and catalytic triad geometry, as supported by long molecular dynamics (MD) simulations in explicit water solvent. In this study, the pH dependence of the catalytic activity and binding of the low-molecular mass inhibitor N-alpha-(2-naphthylsulfonyl-glycyl)-4-amidinophenylalanine-piperidine (alpha-NAPAP) to the wild-type (WT) and deltaK9 thrombin forms were investigated, along with their overall structural stabilities and conformational properties. Two ionizable groups were found to similarly affect the activity of both thrombins. The pKa value of the first ionizable group, assigned to the catalytic His57 residue, was found to be 7.5 and 6.9 in ligand-free deltaK9 and WT thrombin, respectively. Urea-induced denaturation studies showed higher instability of the deltaK9 mutant compared with WT thrombin, and disulfide scrambling experiments proved weakening of the interchain interactions, causing faster release of the reduced A-chain in the mutant enzyme. The sodium ion binding affinity was not significantly perturbed by Lys9 deletion, although the linked increase in intrinsic fluorescence was lower in the mutant. Essential dynamics (ED) analysis highlighted different conformational properties of the two thrombins in agreement with the experimental conformational stability data. Globally, these findings enhanced our understanding of the perturbations triggered by Lys9 deletion, which reduces the overall stability of the molecule, weakens the A-B interchain interactions, and allosterically perturbs the geometry and protonation state of catalytic residues of the enzyme.
研究发现,A链中赖氨酸9残基缺失的天然凝血酶突变体(deltaK9)的催化活性严重受损,这很可能是由于60环构象和催化三联体几何结构的改变所致,在明确的水溶剂中的长时间分子动力学(MD)模拟也支持这一观点。在本研究中,研究了低分子质量抑制剂N-α-(2-萘磺酰基-甘氨酰基)-4-脒基苯丙氨酸-哌啶(α-NAPAP)对野生型(WT)和deltaK9凝血酶形式的催化活性和结合的pH依赖性,以及它们的整体结构稳定性和构象性质。发现两个可电离基团对两种凝血酶的活性有类似影响。在无配体的deltaK9和WT凝血酶中,第一个可电离基团(归因于催化性组氨酸57残基)的pKa值分别为7.5和6.9。尿素诱导的变性研究表明,与WT凝血酶相比,deltaK9突变体的稳定性更高,二硫键重排实验证明链间相互作用减弱,导致突变酶中还原的A链释放更快。赖氨酸9缺失对钠离子结合亲和力没有明显影响,尽管突变体中内在荧光的相关增加较低。主成分动力学(ED)分析突出了两种凝血酶不同的构象性质,这与实验构象稳定性数据一致。总体而言,这些发现加深了我们对赖氨酸9缺失引发的扰动的理解,这种缺失降低了分子的整体稳定性,削弱了A-B链间相互作用,并变构扰动了酶催化残基的几何结构和质子化状态。